AARSD1-CHRNB1 Fusion FISH Probe
The AARSD1-CHRNB1 Fusion FISH Probe is used to confirm a fusion of the AARSD1 and CHRNB1 genes. The fusion of the AARSD1 and CHRNB1 genes has been associated with Uterine Carcinosarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| AARSD1-CHRNB1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-CHRNB1-20-AQAQ | 20 (40 μL) | 200 μL |
|
CHRNB1 Gene Summary
The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome. [provided by RefSeq, Jul 2008]
Gene Name: Cholinergic Receptor Nicotinic Beta 1 Subunit
Chromosome: CHR17: 7348405 -7360932
Locus: 17p13.1
AARSD1 Gene Summary
The Alanyl-tRNA Synthetase Domain Containing 1 (AARSD1) gene is located on chr17 :41102542-41132545 at 17q21.31.
Gene Name: Alanyl-tRNA Synthetase Domain Containing 1
Chromosome: CHR17: 41102542 -41132545
Locus: 17q21.31
Gene Diseases
The AARSD1 CHRNB1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Carcinosarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|